Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeGN HearingGN Hearing Announces Launch of ReSound LiNX 3D™ with Teleaudiology Solution

GN Hearing Announces Launch of ReSound LiNX 3D™ with Teleaudiology Solution

ReSound LiNX 3D™

The innovative ReSound LiNX 3D™ hearing aids are now available in the U.S. market, taking Smart Hearing to unmatched sound quality and enabling people with hearing loss to hear more, do more and be more anywhere in life. Building on GN Hearing’s leadership in Smart Hearing, ReSound LiNX 3D represents a breakthrough in teleaudiology by providing a novel remote fine-tuning solution for users wherever they are.

ReSound LiNX 3D is the only hearing aid with complete remote fine-tuning capabilities. The unique new feature, ReSound Assist allows users to stay in touch with their hearing care professional wherever they are, receiving hearing care and getting new settings securely via the cloud without having to schedule and travel for a clinic appointment.

After an initial consultation and fast and convenient fitting at a hearing care professional’s clinic, users can request fine-tunings based on any hearing difficulty as the situation occurs, rather than trying to remember how to describe it during a visit to the clinic. The hearing care professional can make all fine-tunings remotely to provide an even better hearing care experience for the user.

With ReSound LiNX 3D – GN Hearing’s 5th generation 2.4 GHz wireless technology and 3rd generation binaural directionality – hearing aid users will experience excellent sound quality, including up to 50% better performance versus other products at identifying speech in various environments, will hear up to 80% more sounds around them, and understand up to 40% more speech in noise*. ReSound LiNX 3D delivers clear exceptional speech understanding and the best sense of where sounds are coming from.

A new ReSound Smart 3D app allows users to easily personalize and control their sound at any time on-the-go directly from a smartphone (iPhone, Apple Watch and selected Android models). Available on the App Store and Google Play, the ReSound Smart 3D app empowers users to take even more control of their hearing experience through a built-in guidance and coaching feature, and gives users direct access to their hearing care professional for efficient optimization with ReSound Assist, without the need for an appointment in a clinic.

Today, the average hearing aid user conducts 4-7 follow-up visits to the clinic to optimize their hearing aid settings. GN Hearing’s new remote fine tuning capability has the promise to reduce that number, improving health care outcomes and saving time for the user to focus on other priorities.

“GN Hearing is excited to introduce a quantum leap in sound quality and connectivity, enabling users to take even more control of their personal hearing experience, while offering the option of not having to travel to the clinic,” said Kim Lody, President of GN Hearing North America. “This new teleaudiology solution allows hearing health care professionals to better meet the modern user’s demanding schedule, strengthening their relationship with their patients” she added.

In addition to personalized settings, GN Hearing’s portfolio of Smart Hearing aids offer direct streaming of sound from Apple devices, allowing wearers to utilize their hearing aids as high-quality stereo headphones to talk on the phone, make FaceTime calls and listen to music without the need of an additional remote control, accessory or pendant.

Developed in collaboration with Apple, GN Hearing continues to lead the way in Smart Hearing, introducing the world’s first 2.4 GHz wireless connectivity in 2010, Binaural Directionality in 2012, the first Made for iPhone (MFi) hearing aid in 2013, and the first cloud-based remote fine-tuning today.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy